Javascript must be enabled to continue!
Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans
View through CrossRef
Abstract
Stereotactic radiotherapy (SRT) methods have become common for the treatment of small tumors in various parts of the body. Small field dosimetry has a unique set of challenges when it comes to the pre‐treatment validation of a radiotherapy plan that involves film dosimetry or high‐resolution detectors. Comparison of commercial quality assurance (QA) devices to the film dosimetry method for pre‐treatment evaluation of stereotactic radiosurgery (SRS), fractionated SRT, and stereotactic body radiation therapy treatment plans have been evaluated in this study. Forty stereotactic QA plans were measured using EBT‐XD film, IBA Matrixx Resolution, SNC ArcCHECK, Varian aS1200 EPID, SNC SRS MapCHECK, and IBA myQA SRS. The results of the commercial devices are compared to the EBT‐XD film dosimetry results for each gamma criteria. Treatment plan characteristics such as modulation factor and target volume were investigated for correlation with the passing rates. It was found that all detectors have greater than 95% passing rates at 3%/3 mm. Passing rates decrease rapidly for ArcCHECK and the Matrixx as criteria became more strict. In contrast, EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS passing rates do not decline as rapidly when compared to Matrix Resolution, ArcCHECK, and the EPID. EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS maintain greater than 90% passing rate at 2%/1 mm and greater than 80% at 1%/1 mm. Additionally, the ability of these devices to detect changes in dose distribution due to MLC positioning errors was investigated. Ten VMAT SBRT/SRS treatment plans were created with 6 MV FFF or 10 MV FFF beam energies using Eclipse 15.6. A MATLAB script was used to create two MLC positioning error scenarios from the original treatment plan. It was found that errors in MLC positioning were most reliably detected at 2%/1 mm for high‐resolution detectors and that lower‐resolution detectors did not consistently detect MLC positioning errors.
Title: Evaluation of commercial devices for patient specific QA of stereotactic radiotherapy plans
Description:
Abstract
Stereotactic radiotherapy (SRT) methods have become common for the treatment of small tumors in various parts of the body.
Small field dosimetry has a unique set of challenges when it comes to the pre‐treatment validation of a radiotherapy plan that involves film dosimetry or high‐resolution detectors.
Comparison of commercial quality assurance (QA) devices to the film dosimetry method for pre‐treatment evaluation of stereotactic radiosurgery (SRS), fractionated SRT, and stereotactic body radiation therapy treatment plans have been evaluated in this study.
Forty stereotactic QA plans were measured using EBT‐XD film, IBA Matrixx Resolution, SNC ArcCHECK, Varian aS1200 EPID, SNC SRS MapCHECK, and IBA myQA SRS.
The results of the commercial devices are compared to the EBT‐XD film dosimetry results for each gamma criteria.
Treatment plan characteristics such as modulation factor and target volume were investigated for correlation with the passing rates.
It was found that all detectors have greater than 95% passing rates at 3%/3 mm.
Passing rates decrease rapidly for ArcCHECK and the Matrixx as criteria became more strict.
In contrast, EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS passing rates do not decline as rapidly when compared to Matrix Resolution, ArcCHECK, and the EPID.
EBT‐XD film, SNC SRS MapCHECK, and IBA myQA SRS maintain greater than 90% passing rate at 2%/1 mm and greater than 80% at 1%/1 mm.
Additionally, the ability of these devices to detect changes in dose distribution due to MLC positioning errors was investigated.
Ten VMAT SBRT/SRS treatment plans were created with 6 MV FFF or 10 MV FFF beam energies using Eclipse 15.
6.
A MATLAB script was used to create two MLC positioning error scenarios from the original treatment plan.
It was found that errors in MLC positioning were most reliably detected at 2%/1 mm for high‐resolution detectors and that lower‐resolution detectors did not consistently detect MLC positioning errors.
Related Results
The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma
The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma
Stereotactic radiation technique including single fraction radiosurgery and conventional fractionated stereotactic radiotherapy is widely reported as an effective treatment of pitu...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Developing the advanced dosimetry of linac beam radiotherapy
Developing the advanced dosimetry of linac beam radiotherapy
<p dir="ltr">Photon beams remains the most widely used modality for radiotherapy of cancer worldwide. Continued technological development has enabled increasingly conformal t...
Developing the advanced dosimetry of linac beam radiotherapy
Developing the advanced dosimetry of linac beam radiotherapy
<p dir="ltr">Photon beams remains the most widely used modality for radiotherapy of cancer worldwide. Continued technological development has enabled increasingly conformal t...
Clinical and 18F-FDG PET/CT Imaging Characteristics of Post-radiotherapy Sacral Insufficiency Fractures in Cervical Cancer Patients
Clinical and 18F-FDG PET/CT Imaging Characteristics of Post-radiotherapy Sacral Insufficiency Fractures in Cervical Cancer Patients
Introduction:
Sacral Insufficiency Fractures (SIFs) are a common yet frequently misdiagnosed late complication following pelvic radiotherapy for cervical
cancer...
Thallium SPECT-Based Stereotactic Targeting for Brain Tumor Biopsies
Thallium SPECT-Based Stereotactic Targeting for Brain Tumor Biopsies
MR or CT images acquired under stereotactic conditions are often used to plan and guide brain tumor biopsies. The objective of this study was to design and test a methodology to in...
Radiotherapy refusal in breast cancer with breast-conserving surgery
Radiotherapy refusal in breast cancer with breast-conserving surgery
Abstract
Background
Although radiotherapy after breast-conserving surgery has been the standard treatment for breast cancer, some people still refus...
Current Developments in Radiotherapy Quality Control Methods
Current Developments in Radiotherapy Quality Control Methods
Quality control is of critical importance to ensure the accurate and reliable implementation of treatment in radiotherapy. Radiotherapy is a primary method of treating diseases suc...

